Hernández-Fernández A, Oñate-Sánchez RE, Cabrerizo-Merino MC, de-Arriba-de-la-Fuente F, Heras-Fernando I, Vicente-García V. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT). Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e94-101. 

 

doi:10.4317/medoral.16997

http://dx.doi.org/doi:10.4317/medoral.16997

 

 

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
http://dx.doi.org/10.3322/canjclin.54.1.8

2.
Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol. 2003;30:76-83.
http://dx.doi.org/10.1053/j.seminoncol.2003.11.040
PMid:14727245

3. O’Brien SN, Blijlevens NM, Mahfouz TH, Anaissie EJ. Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program. 2003:438-72.
http://dx.doi.org/10.1182/asheducation-2003.1.438

4. Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant. 2003;31:1-10.
http://dx.doi.org/10.1038/sj.bmt.1703776
PMid:12621500

5. Wardley AM, Jayson GC, Swindell R, Morgenstern GR, Chang J, Bloor R, et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol. 2000;110:292-9.
http://dx.doi.org/10.1046/j.1365-2141.2000.02202.x
PMid:10971384

6. Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol. 1999;17:2446-53.
PMid:10561308

7. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin. 2001;51:290-315.
http://dx.doi.org/10.3322/canjclin.51.5.290

8.
Stiff P. Mucositis associated with stem cell transplantation: current status and innovative ap-proaches to management. Bone Marrow Transplant. 2001;27 Suppl 2:S3-S11.
http://dx.doi.org/10.1038/sj.bmt.1702863
PMid:11436115

9. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant. 2000;25:1269-78.
http://dx.doi.org/10.1038/sj.bmt.1702447
PMid:10871732

10.
Sabater Recolons Mdel M, López López J, Rodríguez de Rivera Campillo ME, Chimenos Küstner E, Conde Vidal JM. Buccodental health and oral mucositis. Clinical study in patients with hematological diseases. Med Oral Patol Oral Cir Bucal. 2006;11:E497-502.
PMid:17072254

11. Scully C, Sonis S, Diz PD. Oral mucositis.
Oral Dis. 2006;12:229-41.
http://dx.doi.org/10.1111/j.1601-0825.2006.01258.x
PMid:16700732

12. Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, et al.
Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation pa-tients: a randomized trial. Blood. 2007;109:2250-5.
http://dx.doi.org/10.1182/blood-2006-07-035022
PMid:17053058

13. Beaven AW, Shea TC. Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies.
Expert Opin Pharmacother. 2006;7:2287-99.
http://dx.doi.org/10.1517/14656566.7.16.2287
PMid:17059384

14. López-Castaño F, Oñate-Sánchez RE, Roldán-Chicano R, Cabrerizo-Merino MC.
Measurement of secondary mucositis to oncohematologic treatment by means of different scale. Review. Med Oral Patol Oral Cir Bucal. 2005;10:412-21.
PMid:16264377

15. Sonis ST, Fey EG. Oral complications of cancer therapy. Oncology (Williston Park). 2002;16:680-6.
PMid:12108892

16. Puyalt Casado M, Jiménez Martinez C, Chimenos Küstner E, López López J, Juliá A. A proto-col for the evaluation and treatment of oral mucositis in patients with hematological malignancies. Med Oral. 2003;8:10-8.
PMid:12556718

17. Hobdell M, Petersen PE, Clarkson J, Johnson N. Global goals for oral health 2020. Int Dent J. 2003;53:285-8.
http://dx.doi.org/10.1111/j.1875-595X.2003.tb00761.x
PMid:14560802

18. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko MK. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer. 1992;69:2469-77.
http://dx.doi.org/10.1002/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W

19. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unan-swered questions.
Oral Oncol. 2003;39:91-100.
http://dx.doi.org/10.1016/S1368-8375(02)00033-7